Find out more about our Academic Medical Centre and efforts in Academic Medicine
Academic Medicine Executive Committee (AM EXCO)
Find out more about what JOAM do to support AM initiatives
Find out more about the Office of Duke-NUS Affairs and Study Trip to Duke Durham
Guidelines, forms, and templates for Academic Medicine.
Metabolic syndrome is the name for a clustering of medical conditions that raises your risk for IHD (Ischaemic Heart disease), Stroke and Type-II Diabetes Mellitus. According to new IDF (International Diabetes Federation) definition, metabolic syndrome is defined as central obesity plus any two of the following risk factors – Hypertension, Raised Fasting Plasma Glucose, Raised triglycerides and Reduced HDL cholesterol. It is estimated that around 20-25 per cent of the world’s adult population have the metabolic syndrome and they are twice as likely to die from and three times as likely to have a heart attack or stroke compared with people without the syndrome. In addition, people with metabolic syndrome have a five fold greater risk of developing type 2 diabetes.
Treating metabolic syndrome consists of multidisciplinary team approach from medical and surgical doctors, psychologists, physiotherapists and dieticians. The team will guide and lead you through evidence-based weight improvement therapy programme to achieve a healthy lifestyle and life-long complete health. Primary interventions consisted of lifestyle modification with healthier diet, increase physical exercises and behavioural changes to aid successful weight loss maintenance. Pharmacotherapy intervention to treat the individual components of the syndrome in order to lower the overall impact on IHD and diabetes risk. Prescriptions of weight-loss medications may be helpful in selective individual by medical practitioners only due to its potential side-effects.